Defining criteria for broadly neutralizing HIV antibodies

Elizabeth-Sharon David-Fung1, Katherine A Belobrajdic1, Jennifer P Macke1

  • 1Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, United States.

PubMed
Summary

A small percentage of HIV-1 patients develop broadly neutralizing antibodies (bnAbs). A new tool, CAByN, helps define and identify these bnAbs from extensive neutralization data.